AstraZeneca Pharmaceuticals LP v. Kennedy
Pending Petition
Issue
Whether the Inflation Reduction Act of 2022 implicates an interest of pharmaceutical manufacturers that is protected by the Due Process Clause.
Jul 24, 2025Application (25A115) to extend the time to file a petition for a writ of certiorari from August 6, 2025 to September 20, 2025, submitted to Justice Alito.
Jul 28, 2025Application (25A115) granted by Justice Alito extending the time to file until September 20, 2025.
Sep 19, 2025Petition for a writ of certiorari filed. (Response due October 24, 2025)Sep 26, 2025Motion to extend the time to file a response from October 24, 2025 to November 24, 2025, submitted to The Clerk.Sep 29, 2025Motion to extend the time to file a response is granted and the time is extended to and including November 24, 2025.
Nov 20, 2025Motion to extend the time to file a response from November 24, 2025 to December 24, 2025, submitted to The Clerk.Nov 21, 2025Motion to extend the time to file a response is granted and the time is further extended to and including December 24, 2025.
Dec 18, 2025Motion to extend the time to file a response from December 24, 2025 to January 2, 2026, submitted to The Clerk.Dec 19, 2025Motion to extend the time to file a response is granted and the time is further extended to and including January 2, 2026.
Jan 2, 2026Brief of respondents Secretary of Health and Human Services, Robert F. Kennedy, et al. in opposition filed.Jan 2, 2026Waiver of the 14-day waiting period for the distribution of the petition pursuant to Rule 15.5 filed by petitioner.Jan 7, 2026DISTRIBUTED for Conference of 1/23/2026.
Jan 7, 2026Reply of petitioners AstraZeneca Pharmaceuticals LP, et al. filed. (Distributed)Jan 22, 2026Rescheduled.
Recommended Citation: AstraZeneca Pharmaceuticals LP v. Kennedy, SCOTUSblog, https://www.scotusblog.com/cases/astrazeneca-pharmaceuticals-lp-v-kennedy/